Correlation Between ANI Pharmaceuticals and CV Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ANI Pharmaceuticals and CV Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ANI Pharmaceuticals and CV Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ANI Pharmaceuticals and CV Sciences, you can compare the effects of market volatilities on ANI Pharmaceuticals and CV Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ANI Pharmaceuticals with a short position of CV Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of ANI Pharmaceuticals and CV Sciences.

Diversification Opportunities for ANI Pharmaceuticals and CV Sciences

0.26
  Correlation Coefficient

Modest diversification

The 3 months correlation between ANI and CVSI is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding ANI Pharmaceuticals and CV Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CV Sciences and ANI Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ANI Pharmaceuticals are associated (or correlated) with CV Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CV Sciences has no effect on the direction of ANI Pharmaceuticals i.e., ANI Pharmaceuticals and CV Sciences go up and down completely randomly.

Pair Corralation between ANI Pharmaceuticals and CV Sciences

Given the investment horizon of 90 days ANI Pharmaceuticals is expected to generate 0.2 times more return on investment than CV Sciences. However, ANI Pharmaceuticals is 4.96 times less risky than CV Sciences. It trades about 0.03 of its potential returns per unit of risk. CV Sciences is currently generating about -0.04 per unit of risk. If you would invest  5,797  in ANI Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of  67.00  from holding ANI Pharmaceuticals or generate 1.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

ANI Pharmaceuticals  vs.  CV Sciences

 Performance 
       Timeline  
ANI Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ANI Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's forward indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.
CV Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CV Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, CV Sciences is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

ANI Pharmaceuticals and CV Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ANI Pharmaceuticals and CV Sciences

The main advantage of trading using opposite ANI Pharmaceuticals and CV Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ANI Pharmaceuticals position performs unexpectedly, CV Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CV Sciences will offset losses from the drop in CV Sciences' long position.
The idea behind ANI Pharmaceuticals and CV Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world